Inactive Instrument

Eucrates Biomedical Acquisition Corp. Stock

EUCR

VGG3141W1068

Chart Eucrates Biomedical Acquisition Corp.

Duration

Period

Style

Dynamic Chart

Latest news about Eucrates Biomedical Acquisition Corp.

Eucrates Biomedical Acquisition Corp.(NasdaqCM:EUCR) dropped from NASDAQ Composite Index	23-04-26	CI
Eucrates Biomedical Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-13	CI
Eucrates Biomedical Acquisition Corp. Auditor Raises 'Going Concern' Doubt	23-04-12	CI
Eucrates Biomedical Acquisition to Dissolve, Liquidate	23-04-11	MT
Eucrates Biomedical Acquisition Corp. announced that it has received $0.096 million in funding from Eucrates Llc	23-02-14	CI
Eucrates Biomedical Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Eucrates Biomedical Acquisition Corp. announced that it has received $0.6 million in funding from Eucrates Llc	22-11-06	CI
Eucrates Biomedical Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15	CI
Eucrates Biomedical Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-23	CI
Eucrates Biomedical Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-11	CI
Eucrates Biomedical Acquisition Corp. Auditor Raises 'Going Concern' Doubt	22-04-10	CI
Eucrates Biomedical Acquisition Corp. announced that it expects to receive $0.6 million in funding from Eucrates Llc	22-01-19	CI
Eucrates Biomedical Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-22	CI
Eucrates Biomedical Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-07-16	CI
Eucrates Biomedical Acquisition : Receives Non-Compliance Notice from Nasdaq	21-06-01	MT

More news

Press releases Eucrates Biomedical Acquisition Corp.

EUCRATES BIOMEDICAL ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	23-04-13	AQ
Eucrates Biomedical Acquisition : Announces Liquidation - Form 8-K	23-04-11	PU
EUCRATES BIOMEDICAL ACQUISITION CORP. : Other Events, Financial Statements and Exhibits (form 8-K)	23-04-11	AQ
Eucrates Biomedical Acquisition Corp. Announces Liquidation	23-04-11	PR
Eucrates Biomedical Acquisition : New Financial Obligation - Form 8-K	23-04-03	PU

More press releases

Managers and Directors - Eucrates Biomedical Acquisition Corp.

Managers	Title	Age	Since
Evangelos Vergetis FOU	Founder	45	20-08-20
Parag Phoolchand Saxena FOU	Founder	69	20-08-20
Gonzalo Cordova DFI	Director of Finance/CFO	70	-

Members of the board	Title	Age	Since
William Campbell BRD	Director/Board Member	78	-
Parag Phoolchand Saxena FOU	Founder	69	20-08-20
Nina Shapiro BRD	Director/Board Member	76	-

More insiders

Eucrates Biomedical Acquisition Corp. is a blank check company. The Company is formed for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation with, purchasing all or substantially all of the assets of, entering into contractual arrangements with, or engaging in any other similar business combination with one or more businesses or entities. The Company intends to focus on businesses focusing on the biomedical or healthcare-related industries. The Company is not engaged in any business operations and has generated any revenue.

Sector

Investment Holding Companies

More about the company

Sector Shell Companies

	1st Jan change	Capi.
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+119.94%	5.26B
SCREAMING EAGLE ACQUISITION CORP.	+1.60%	1.01B
CHURCHILL CAPITAL CORP VII	+2.29%	983M
APPLE ISPORTS GROUP, INC.	+41.91%	872M
PERELLA WEINBERG PARTNERS	+27.64%	834M
ARES ACQUISITION CORPORATION II	+1.68%	663M
E7 GROUP	+0.54%	617M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ALTC ACQUISITION CORP.	+23.11%	560M

Shell Companies